Jill Lee is the Senior Director and US Lead for Regulatory Policy & Intelligence at Novo Nordisk. Jill has over 18 years of industry experience and began her career providing legal support in the regulation of medical devices and drugs. She joined Novo Nordisk’s Regulatory Policy team 7 years ago and has been the US policy lead on digital health, combination products and patient-focused drug development.  She holds a JD from Rutgers University and a BA from Mary Washington University.